
Kobayashi Pharmaceutical Co Ltd
TSE:4967

Intrinsic Value
The intrinsic value of one
Kobayashi Pharmaceutical Co Ltd
stock under the Base Case scenario is
6 578.61
JPY.
Compared to the current market price of 5 358 JPY,
Kobayashi Pharmaceutical Co Ltd
is
Undervalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Kobayashi Pharmaceutical Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Kobayashi Pharmaceutical Co Ltd
Balance Sheet Decomposition
Kobayashi Pharmaceutical Co Ltd
Current Assets | 144.5B |
Cash & Short-Term Investments | 65.7B |
Receivables | 49.4B |
Other Current Assets | 29.3B |
Non-Current Assets | 120.9B |
Long-Term Investments | 27.3B |
PP&E | 67.4B |
Intangibles | 20.7B |
Other Non-Current Assets | 5.5B |
Free Cash Flow Analysis
Kobayashi Pharmaceutical Co Ltd
JPY | |
Free Cash Flow | JPY |
Earnings Waterfall
Kobayashi Pharmaceutical Co Ltd
Revenue
|
165.6B
JPY
|
Cost of Revenue
|
-78B
JPY
|
Gross Profit
|
87.6B
JPY
|
Operating Expenses
|
-62.7B
JPY
|
Operating Income
|
24.9B
JPY
|
Other Expenses
|
-14.8B
JPY
|
Net Income
|
10.1B
JPY
|
Profitability Score
Profitability Due Diligence
Kobayashi Pharmaceutical Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Score
Kobayashi Pharmaceutical Co Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Kobayashi Pharmaceutical Co Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Score
Kobayashi Pharmaceutical Co Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Kobayashi Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Kobayashi Pharmaceutical Co Ltd
is 5 849.7 JPY
with a low forecast of 5 050 JPY and a high forecast of 7 350 JPY.
Dividends
Current shareholder yield for Kobayashi Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Kobayashi Pharmaceutical Co Ltd
stock under the Base Case scenario is
6 578.61
JPY.
Compared to the current market price of 5 358 JPY,
Kobayashi Pharmaceutical Co Ltd
is
Undervalued by 19%.